← Back to Search

Tablet-Based Sustained Care for Smoking Cessation

N/A

Waitlist Available

Led By Richard Brown, Ph.D.

Research Sponsored by University of Texas at Austin

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1, 3, and 6 months after hospital discharge

Awards & highlights

Study Summary

This trial is testing an intervention to help psychiatric patients quit smoking, with the goal to reduce tobacco-related cancers in Texas.

Who is the study for?

This trial is for adults over 18 who smoke at least 5 cigarettes a day when not hospitalized, can give informed consent, and are able to attend all study visits. It's not for those with dementia or severe cognitive issues, substance detox needs, no phone access or stable address, institutional discharge plans post-hospitalization, pregnancy/breastfeeding women, or those with health risks from nicotine patches.Check my eligibility

What is being tested?

The trial tests a tablet-based program designed to help people quit smoking after psychiatric hospitalization. It includes motivational counseling without the need for professional counselors and provides resources like quitline referrals and nicotine patches upon leaving the hospital.See study design

What are the potential side effects?

While specific side effects of the tablet-based intervention aren't mentioned since it's behavioral therapy rather than medication, potential side effects may relate to nicotine patch use which can include skin irritation where the patch is applied.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ first month following hospital discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~first month following hospital discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and first month following hospital discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Smoking cessation

Secondary outcome measures

Number of quit attempts

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Tablet-based Sustained CareExperimental Treatment1 Intervention

Intervention to support sustained smoking cessation.

Group II: Usual CareActive Control1 Intervention

Standard hospital care: : A brief (5-10 min.) tobacco education session from a hospital nurse, along with educational materials about quitting and a quitline brochure.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor

350 Previous Clinical Trials

80,734 Total Patients Enrolled

Ascension Seton Shoal CreekUNKNOWN

Cancer Prevention Research Institute of TexasOTHER

50 Previous Clinical Trials

98,188 Total Patients Enrolled

Media Library

Tablet-based sustained care Clinical Trial Eligibility Overview. Trial Name: NCT05672914 — N/A

Smoking Cessation Research Study Groups: Tablet-based Sustained Care, Usual Care

Smoking Cessation Clinical Trial 2023: Tablet-based sustained care Highlights & Side Effects. Trial Name: NCT05672914 — N/A

Tablet-based sustained care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05672914 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there currently an opportunity for individuals to become involved in the research?

"According to the information shared on clinicaltrials.gov, this trial concluded recruitment on December 21st 2022; nonetheless, there are 139 other trials actively seeking out participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Intervening to Promote Tobacco Cessation Following Psychiatric Hospitalization

Richard A. Brown 2023. "Intervening to Promote Tobacco Cessation Following Psychiatric Hospitalization". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05672914.